October 19, 2026

Tempus Presents Data Demonstrating AI-Enabled Pre-Screening Can Help Identify Patients for Biomarker Testing in NSCLC

Tempus: Study presented at ESMO evaluated more than 60,000 advanced NSCLC cases and found greater than 80% sensitivity across all 12 biomarkers using routine H&E pathology images CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM) today...

recent articles

4 March, 2020  8:00 PST | 11:00 EST | 16:00 GMT CLICK HERE TO REGISTER In this 30 minute webinar, researchers and pathologists from the University of New Mexico will discuss their recently published study using the HALO...

Williston, VT  — MBF Bioscience’s revolutionary light sheet microscope system, ClearScope, sets a new standard for microscopic imaging. The new decade is poised to bring about incredible scientific innovations, and MBF Bioscience is...

OS-SiA, an AI enabled scanner to revolutionize cervical cancer screening Complete Solution to Improve Medical Research and Digitize Clinical Workflow San Jose, California, January 31st, 2020 - OptraSCAN®, the leading On-Demand...

January 30, 2020

9 holes, 2 balls

When I was 12 years old I asked my father for an allowance. Without hesitating he said “sure”. The next thing I knew I had a part-time job at a body shop a few blocks from our house, across the Des Plaines River in suburban Chicago....

Dr. Leena Strauss has taught disease model pathology for the past decade. She is based at the University of Turku’s Institute of Biomedicine as a lecturer and researcher. Leena is one of the first adopters of digitizing teaching in pathology:...

OR

platinum partners

gold partners

Silver Partners

Media Partners